IQ

IQ-AI LtdLSE IQ-AI Stock Report

Last reporting period 30 Jun, 2023

Updated 28 Oct, 2024

Last price

Market cap $B

0.003

Micro

Exchange

XLON - London Stock Exchange

IQAI.L Stock Analysis

IQ

Uncovered

IQ-AI Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

7/100

Low score

Market cap $B

0.003

Dividend yield

Shares outstanding

182.62 B

IQ-AI Ltd. is a holding company, which engages in the provision of clinical treatments to patients in the field of medical imaging diagnostics. The firm operates through two segments: holding company expenses and medical software. Its subsidiaries include Imaging Biometrics LLC and d Stone Checker Software Limited (SC). Imaging Biometrics LLC is a healthcare imaging software company. In addition to providing regulatory consulting services, Imaging Biometrics LLC supplies medical technology solutions and has a neuroimaging product portfolio. SC is a supplier of technology solutions in the field of kidney stone analysis.

View Section: Eyestock Rating